These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 6117849)

  • 21. Ontogeny of nigrostriatal dopamine neuron autoreceptors: iontophoretic studies.
    Wang L; Pitts DK
    J Pharmacol Exp Ther; 1995 Jan; 272(1):164-76. PubMed ID: 7815330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP; Markstein R
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions.
    Fung YK; Uretsky NJ
    J Pharmacol Exp Ther; 1980 Sep; 214(3):651-6. PubMed ID: 6772760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dopamine concentration in the nigro-striatal system during elaboration and performance of conditioned avoidance reactions of various complexity in rats].
    Saul'skaia NB
    Fiziol Zh SSSR Im I M Sechenova; 1981 Jun; 67(6):797-803. PubMed ID: 7274479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for selective and long-lasting stimulation of "regulatory" dopamine-receptors by bromocriptine (CB 154).
    di Chiara G; Porceddu ML; Vargiu L; Stefanini E; Gessa GL
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Nov; 300(3):239-45. PubMed ID: 600311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excitation-mediating and inhibition-mediating dopamine-receptors: a new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data.
    Cools AR; Van Rossum JM
    Psychopharmacologia; 1976 Feb; 45(3):243-54. PubMed ID: 175391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine receptor mediated inhibition by bromocriptine of accelerator nerve stimulation effects in the pithed cat [proceedings].
    Scholtysik G; Berde B
    Br J Pharmacol; 1978 Mar; 62(3):379P. PubMed ID: 638321
    [No Abstract]   [Full Text] [Related]  

  • 28. On the mechanism of the antiparkinsonian action of 1-DOPA and bromocriptine: a theoretical and experimental analysis of dopamine receptor sub- and supersensitivity.
    Agnati LF; Fuxe K
    J Neural Transm Suppl; 1980; (16):69-81. PubMed ID: 7000979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The morphology, electrophysiology and pharmacology of the substantia nigra].
    Gu YH
    Sheng Li Ke Xue Jin Zhan; 1980 Feb; 11(2):120-7. PubMed ID: 6107991
    [No Abstract]   [Full Text] [Related]  

  • 30. Adaptive changes in the dopamine system produced by chronic ethanol feeding.
    Hoffman PL; Tabakoff B
    Drug Alcohol Depend; 1979; 4(3-4):255-60. PubMed ID: 43240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Further studies on dopamine receptors in the brain of Helix aspersa [proceedings].
    Batta S; Walker RJ; Woodruff GN
    Br J Pharmacol; 1979 May; 66(1):127P. PubMed ID: 454922
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuropharmacology of synthetic ergot derivatives in man.
    Lemberger L; Crabtree RE
    Adv Biochem Psychopharmacol; 1980; 23():117-24. PubMed ID: 6104905
    [No Abstract]   [Full Text] [Related]  

  • 33. Multiple dopamine receptors: functional implications.
    Schwartz JC
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():1A-2A. PubMed ID: 1498771
    [No Abstract]   [Full Text] [Related]  

  • 34. [Role of catecholaminergic systems of the bird brain in regulating gonadal function].
    Nikonenko AG; Ptitsa AN; Tolkachev PS
    Fiziol Zh (1978); 1988; 34(6):45-9. PubMed ID: 3248605
    [No Abstract]   [Full Text] [Related]  

  • 35. [The experimental development of the concept of O. S. Adrianov on the correlation of functional and neurochemical processes: regulatory peptides in mediator system dysfunction].
    Popova NS; Dovedova EL; Kachalova LM; Gershteĭn LM
    Usp Fiziol Nauk; 2000; 31(1):71-80. PubMed ID: 10752133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamic profile of CQP 201-403, a novel 8 alpha-amino-ergoline.
    Flückiger E; Briner U; Clark B; Closse A; Enz A; Gull P; Hofmann A; Markstein R; Tolcsvai L; Wagner HR
    Experientia; 1988 May; 44(5):431-6. PubMed ID: 3371446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central dopamine receptors.
    Flückiger E; Vigouret JM
    Postgrad Med J; 1981; 57 Suppl 1():55-61. PubMed ID: 6117849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
    Cubeddu LX; Hoffmann IS; James MK; Niedzwiecki DM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):680-5. PubMed ID: 6887008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for the existence of regulatory DA receptors in the substantia nigra.
    Di Chiara G; Mereu GP; Vargiu L; Porceddu ML; Mulas A; Trabucchi M; Spano PF
    Adv Biochem Psychopharmacol; 1977; 16():477-81. PubMed ID: 18896
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacology and biochemistry of dopamine receptors in the central nervous system and peripheral tissue.
    Memo M; Missale C; Carruba MO; Spano PF
    J Neural Transm Suppl; 1986; 22():19-32. PubMed ID: 2431109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.